Target intelligence / Profile preview

Actomyosin complex (Actomyosin)

Target
Actomyosin
Molecular classification
Protein complex, Cytoskeletal protein, Motor protein, Enzyme
01

Overview

The actomyosin complex is a fundamental molecular machine composed of actin filaments and myosin motor proteins, primarily responsible for converting chemical energy from ATP hydrolysis into mechanical work. In muscle cells, this interaction facilitates the sliding filament mechanism, which is the basis for muscle contraction and force generation. In non-muscle cells, the complex plays critical roles in maintaining cell structure, driving cytokinesis during cell division, and enabling cell migration. The regulation of the actomyosin complex is highly complex, involving calcium signaling, phosphorylation of myosin light chains, and various regulatory proteins like troponin and tropomyosin (Source: UniProt, PubMed). Clinically, the actomyosin complex is a major therapeutic target for cardiovascular diseases. Drugs such as mavacamten act as cardiac myosin inhibitors to treat hypertrophic cardiomyopathy by reducing excessive contractility, while activators like omecamtiv mecarbil are designed to enhance cardiac output in patients with heart failure with reduced ejection fraction (Source: NIH, StatPearls). Beyond cardiology, the complex is studied in oncology for its role in the mechanical changes required for cancer cell invasion and metastasis. Understanding the isoform-specific interactions within the actomyosin complex is essential for developing targeted therapies that minimize systemic side effects (Source: Wikipedia, Peer-reviewed journals).

Other names
Actin-myosin complexMyosin-actin complexActomyosin ATPase complex
02

Mechanism of action

Modulation of myosin ATPase activity, stabilization of the actin-myosin cross-bridge, or inhibition of the power stroke to alter contractile force.

03

Biological functions

Muscle contractionCell motilityCytokinesisIntracellular transportCell shape maintenanceSignal transduction
04

Disease associations

Cardiovascular diseaseHeart failureHypertrophic cardiomyopathyDilated cardiomyopathyCancer metastasisMyopathy
05

Safety considerations

Risk of heart failure due to excessive systolic inhibitionArrhythmiasHypotensionSkeletal muscle weaknessOff-target effects on non-cardiac myosin isoforms
06

Interacting drugs

Omecamtiv mecarbil

5 more in the full profile.

07

Biomarkers

Cardiac troponin I (cTnI)Cardiac troponin T (cTnT)N-terminal pro-b-type natriuretic peptide (NT-proBNP)Myosin light chain phosphorylation

Beyond the preview

Go deeper on Actomyosin complex (Actomyosin).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actomyosin complex (Actomyosin).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call